Legal & General Group’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.8K | Buy |
6,985
+1,640
| +31% | +$8.4K | ﹤0.01% | 2784 |
|
|
2025
Q1 | $7.32K | Sell |
5,345
-32,616
| -86% | -$44.7K | ﹤0.01% | 3225 |
|
|
2024
Q4 | $117K | Hold |
37,961
| – | – | ﹤0.01% | 2709 |
|
|
2024
Q3 | $292K | Sell |
37,961
-120
| -0.3% | -$924 | ﹤0.01% | 2614 |
|
|
2024
Q2 | $327K | Buy |
38,081
+1,674
| +5% | +$14.4K | ﹤0.01% | 2571 |
|
|
2024
Q1 | $289K | Hold |
36,407
| – | – | ﹤0.01% | 2613 |
|
|
2023
Q4 | $360K | Sell |
36,407
-3,515
| -9% | -$34.8K | ﹤0.01% | 2573 |
|
|
2023
Q3 | $450K | Sell |
39,922
-652
| -2% | -$7.34K | ﹤0.01% | 2478 |
|
|
2023
Q2 | $135K | Buy |
40,574
+21,883
| +117% | +$72.7K | ﹤0.01% | 2807 |
|
|
2023
Q1 | $73.8K | Buy |
18,691
+1,223
| +7% | +$4.83K | ﹤0.01% | 2820 |
|
|
2022
Q4 | $127K | Buy |
17,468
+5,889
| +51% | +$42.7K | ﹤0.01% | 2760 |
|
|
2022
Q3 | $42K | Buy |
11,579
+3,935
| +51% | +$14.3K | ﹤0.01% | 3015 |
|
|
2022
Q2 | $35K | Sell |
7,644
-3,753
| -33% | -$17.2K | ﹤0.01% | 3078 |
|
|
2022
Q1 | $86K | Hold |
11,397
| – | – | ﹤0.01% | 2902 |
|
|
2021
Q4 | $125K | Buy |
+11,397
| New | +$125K | ﹤0.01% | 2861 |
|